A trial comparing the effect and safety of insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes.
  • NCT03377699
  • dott.ssa Marina Scavini
  • dott.ssa Amelia Caretto, dott.ssa Alice Burini
  • Interventional
  • Trial comparing the effect and safety of insulin degludec once daily with insulin detemir
    once daily or twice daily both in combination with insulin aspart 2-4 times daily with meals in
    pregnant women with type 1 diabetes mellitus.

  • This is a randomised (1:1), open-label, parallel, multi-centre, multi-national, treat-to-target, active
    controlled trial.

  • Type 1 diabetes
  • Treatment
  • Phase 3
  • Parallel
  • Randomized
  • 5
  • Marina
  • Scavini
  • 0226432419
  • scavini.marina@hsr.it
  • Completed